Breaking News Instant updates and real-time market news.

VRTX

Vertex

$87.65

1.23 (1.42%)

08:38
10/06/16
10/06
08:38
10/06/16
08:38

Vertex Orkambi checks positive, says JMP Securities

After conducting checks with doctors, JMP Securities analyst Liisa Bayko says that uptake of Vertex's Orkambi drug among 6-11 year old children appears to be "rapid." Bayko expects Orkambi's market share in the age range to reach 70% within six months. She reiterates a $103 price target and Outperform rating on the stock.

  • 07

    Oct

  • 06

    Nov

VRTX Vertex
$87.65

1.23 (1.42%)

09/15/16
STFL
09/15/16
NO CHANGE
STFL
Vertex weakness creates attractive entry point, says Stifel
After Vertex made a number of negative announcements about its Orkambi drug, including its statement that the drug has "reached pretty much peak penetration in the U.S.," Stifel analyst Adam Walsh noted that the company also said that no chest tightness "has been observed to date with VX-661/Kalydeco." The analyst indicates that he believes that this attribute should enable those patients not taking Orkambi due to side effects to use VX-661/Kalydeco. He raised his price target on Vertex to $109 from $105 and says that the stock has reached an attractive entry point.
09/22/16
PIPR
09/22/16
NO CHANGE
Target $129
PIPR
Overweight
Vertex recent weakness brings buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff views the weakness in shares of Vertex Pharmaceuticals following the company's recent Q3 guidance as a buying opportunity ahead of Orkambi's September 30 PDUFA date in homozygous F508del children. Label expansion for Orkambi should drive cystic fibrosis sales to $478M in Q4, Tenthoff tells investors in a research note. He points out that Vertex will announce data at the North American Cystic Fibrosis Conference from October 27-29. The analyst reiterates an Overweight rating on the shares with a $129 price target.
09/29/16
RBCM
09/29/16
NO CHANGE
RBCM
Vertex should be bought on weakness, says RBC Capital
After Vertex lowered its 2016 Orkambi revenue guidance, RBC Capital analyst Michael Yee says that the news "was not a surprise." The analyst remains upbeat on the company's triple CF treatment, and he recommends buying the stock on weakness. He keeps an Outperform rating on the shares.
09/29/16
JMPS
09/29/16
NO CHANGE
JMPS
Vertex Orkambi approval should drive growth, says JMP Securities
JMP Securities analyst Liisa Bayko says that FDA approval of Vertex's Orkambi in the 6-11 year old population should enable the company to grow in Q4 after a temporary slowdown in Q3. However, the analyst expects Q4 Orkambi sales to come in at $285M, versus the consensus outlook of $295M. She keeps a $103 price target and Outperform rating on the shares.

TODAY'S FREE FLY STORIES

03:20
06/28/17
06/28
03:20
06/28/17
03:20
General news
FX Action: USD-CAD extended its run lower »

FX Action: USD-CAD…

03:15
06/28/17
06/28
03:15
06/28/17
03:15
General news
Breaking General news story  »

San Francisco Federal…

02:45
06/28/17
06/28
02:45
06/28/17
02:45
General news
FX Update: The euro's ascent has continued »

FX Update: The…

MRSN

Mersana Therapeutics

21:10
06/27/17
06/27
21:10
06/27/17
21:10
Syndicate
Mersana Therapeutics 5M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BLUE

bluebird bio

$106.90

-4.2 (-3.78%)

21:09
06/27/17
06/27
21:09
06/27/17
21:09
Syndicate
bluebird bio 3.81M share Secondary priced at $105.00 »

Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ADNT

Adient

$63.20

-1.63 (-2.51%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Conference/Events
Adient to hold a meeting »

EVP & CFO Stafeil,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

GIS

General Mills

$55.52

-0.65 (-1.16%)

, MON

Monsanto

$117.25

-0.55 (-0.47%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$55.52

-0.65 (-1.16%)

MON

Monsanto

$117.25

-0.55 (-0.47%)

PAYX

Paychex

$58.62

-0.62 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 12

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:32
06/27/17
06/27
19:32
06/27/17
19:32
Periodicals
Apple looks to hire 'Siri Event Maven,' 9to5Mac reports »

An Apple job listing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

, TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

19:22
06/27/17
06/27
19:22
06/27/17
19:22
Periodicals
Toshiba to face holder wrath after failing to sell chip unit, Reuters says »

Toshiba is anticipated to…

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$150.58

-3.01 (-1.96%)

19:21
06/27/17
06/27
19:21
06/27/17
19:21
Periodicals
Facebook previously explored effort to promote flu shots, CNBC reports »

Facebook was working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:15
06/27/17
06/27
19:15
06/27/17
19:15
Hot Stocks
Munster lays out five-year Apple model, sees 'Apple Glasses' wearable in 2020 »

Gene Munster, a longtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

19:02
06/27/17
06/27
19:02
06/27/17
19:02
Hot Stocks
Senator urges FTC oversight of Google in wake of Europe fine »

Senator Richard…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

APO

Apollo Global

$25.90

-0.33 (-1.26%)

18:58
06/27/17
06/27
18:58
06/27/17
18:58
Periodicals
Apollo Global hits record-breaking $23.5B target for buyout fund, WSJ says »

Private equity firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$55.43

-1.13 (-2.00%)

18:54
06/27/17
06/27
18:54
06/27/17
18:54
Periodicals
Judge says FTC suit against Qualcomm can proceed, Reuters reports »

A federal judge ruled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNEGY

Linde

$19.25

0.08 (0.42%)

18:53
06/27/17
06/27
18:53
06/27/17
18:53
Periodicals
Linde unit agrees to $20M settlement deal in whistleblower case, Reuters says »

Linde's Lincare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCHC

HC2 Holdings

$5.82

0.03 (0.52%)

18:50
06/27/17
06/27
18:50
06/27/17
18:50
Hot Stocks
HC2 Holdings subsidiary to acquire major interest in DTVA »

HC2 Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.54

-0.38 (-0.58%)

18:38
06/27/17
06/27
18:38
06/27/17
18:38
Periodicals
Merck's cholesterol drug anacetrapib could serve as catalyst, Barron's reports »

Merck announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

TROX

Tronox

$13.52

-0.25 (-1.82%)

18:37
06/27/17
06/27
18:37
06/27/17
18:37
Hot Stocks
Tronox elects Kaufthal as non-executive chairman »

Tronox announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

, CST

CST Brands

$48.53

-0.01 (-0.02%)

18:19
06/27/17
06/27
18:19
06/27/17
18:19
Hot Stocks
Alimentation Couche-Tard cleared in Canada for acquisition of CST Brands »

Alimentation Couche-Tard…

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

CST

CST Brands

$48.53

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSLI

Merus Labs

$1.23

-0.0015 (-0.12%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Merus Labs reminds shareholders to vote for arrangement with Norgine »

Merus Labs International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGI

Endurance

$8.20

-0.15 (-1.80%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Endurance chief administration officer Andreasen to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$186.97

0.68 (0.37%)

17:41
06/27/17
06/27
17:41
06/27/17
17:41
Hot Stocks
Huntington Ingalls receives contract modifications to incorporate upgrades »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$56.18

-0.55 (-0.97%)

17:34
06/27/17
06/27
17:34
06/27/17
17:34
Hot Stocks
International Paper agrees to settle Kleen Products class action litigation »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.67

0.0385 (6.10%)

17:33
06/27/17
06/27
17:33
06/27/17
17:33
Syndicate
Houston American Energy requests withdrawal of registration statement »

The company determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$22.82

0.04 (0.18%)

, RYI

Ryerson

$9.00

-0.1 (-1.10%)

17:24
06/27/17
06/27
17:24
06/27/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$22.82

0.04 (0.18%)

RYI

Ryerson

$9.00

-0.1 (-1.10%)

AVAV

AeroVironment

$32.49

1.52 (4.91%)

CAMP

CalAmp

$19.25

-0.37 (-1.89%)

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

WLL

Whiting Petroleum

$5.48

0.04 (0.74%)

OAS

Oasis Petroleum

$7.93

0.21 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 03

    Jul

  • 04

    Jul

  • 05

    Jul

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.